PAAFFNEURIZON THERAPEUTICS LTD.
Price Chart
Loading chart...
About NEURIZON THERAPEUTICS LTD. (PAAFF)
NEURIZON THERAPEUTICS LTD. (PAAFF) is a N/A company whose shares trade over-the-counter on the Pink tier.
PAA is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA's subsidiary, Epichem, which is a highly successful contract medicinal chemistry company that generates significant annual revenues.
PAAFF key facts
- Ticker symbol
- PAAFF
- Market tier
- Pink
- Country of incorporation
- AU
- Shares outstanding
- 315,846,053
- Reporting standard
- International Reporting: ASX - Australian Securities Exchange
- Audit status
- Audited
- Fiscal year end
- 6/30
Explore more: Pink stocks · OTC stocks starting with P
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for NEURIZON THERAPEUTICS LTD. (PAAFF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
Popular OTC Companies to Explore
Discover other OTC market listed companies:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...